Quantcast
Channel: RT: For Decision Makers in Respiratory Care » Ventilation Products
Viewing all 104 articles
Browse latest View live

COPD: Adding In-home NIV to Oxygen Therapy Improves Outcomes

$
0
0

New research published in JAMA and presented at ATS 2017 found that COPD patients benefited from home oxygen combined with noninvasive ventilation.

As part of the study, which was funded by Philips, researchers randomly assigned patients with persistent hypercapnia after a COPD flare-up to home oxygen alone (n = 59) or home oxygen plus home NIV (n = 57).

Sixty-four patients completed the 12-month study, with 28 receiving home oxygen alone and 36 receiving home oxygen plus home NIV. The median time to readmission or death was 4.3 months in the home oxygen plus home NIV group vs 1.4 months in the home oxygen alone group. The 12-month risk of readmission or death was 63 percent in the home oxygen plus home NIV group vs 80 percent in the home oxygen alone group. At 12 months, 16 patients had died in the home oxygen plus home NIV group vs 19 in the home oxygen alone group.

Several limitations of the study are noted in the article, including that the lack of a double-blind design for this trial is a potential criticism. However, the use of a sham device would have the potential to worsen respiratory failure.

“These data support the screening of patients with COPD after receiving acute noninvasive ventilation to identify persistent hypercapnia and introduce home noninvasive ventilation,” the authors write.

In a Philips press release, Dr Teofilo Lee-Chiong Jr., Chief Medical Liaison at Philips, said, “This study shows that home noninvasive ventilation is a potent, therapeutic tool that clinicians can use to help keep patients with advanced COPD out of the hospital. We hope that this will, in turn, allow them to lead healthier and more active lives at home.”


Vortran Launches New Automatic Resuscitator

$
0
0

Vortran Medical has been granted FDA 510K and CE certification approval for its new automatic resuscitator called the GO2Vent (Gas Operated Ventilator).

The latest addition to their product line offers an option for ventilation of patients during an MRI or CT scan. The GO2Vent has been tested per FDA regulations by Dr Frank Shellock to meet the MRI compatibility testing and has been approved as a MR conditional device, according to a Vortran press release.

The new model uses copper springs to remove the chance of artifacts in the MRI picture. The GO2Vent can be used on a wide patient population from 10kg and above and can be used for post-operative transport, isolation areas, emergency use and disaster management.

The new GO2Vent offers the user an ability to save on oxygen consumption now with an easily changeable FiO2 controller which allows the clinician to easily change from 100% O2 down to 50% to save gas especially when using a tank during a transportation.

The device has changed colors to blue and offers clinicians a simple three step set up guide right on the device to easily and rapidly set up the resuscitator on a patient especially during an emergency type situation when time is of the essence.

VOCSN Earns MedTech Breakthrough Award

$
0
0

Ventec Life Systems’ VOCSN unified respiratory system has been selected as winner of the “Best New Therapeutic Technology Solution” award as part of the annual MedTech Breakthrough Awards program, according to a MedTech press announcement.

 

VOCSN was selected as a MedTech Breakthrough Award winner for “breaking through” a traditionally complex system of disparate respiratory therapeutic devices. In treating respiratory issues, caregivers have historically been tasked with managing up to five separate devices with their own complex operating systems.

VOCSN is the first portable unified respiratory system that integrates five product technologies into a single device: ventilation, oxygen therapy, cough assist, suction, and nebulization. The device is 70% lighter and smaller than existing machines and includes eight pending patents, according to the company.

The device provides an integrated solution that is designed to improve care for patients with neuromuscular disease (eg Muscular Dystrophies, ALS), impaired lung function (eg COPD, cystic fibrosis, lung cancers, emphysema), spinal cord injury, and pediatric development complication (eg premature births, chronic lung disease).

“Companies like Ventec are truly setting the standard for innovation and creativity with health and medical technology,” said James Johnson, managing director, MedTech Breakthrough. “The judges were impressed with the ingenuity displayed in designing VOCSN as a groundbreaking portable life support device that combines five respiratory therapies – Ventilation, Oxygen, Cough, Suction, and Nebulization into a single unified system. We congratulate Ventec on their well-deserved industry recognition.”

“It is an incredible honor to be selected among the best from the thousands of MedTech Breakthrough Award entries this year,” stated Doug DeVries, Founder and Chief Executive Officer at Ventec. “We are pleased to have VOCSN recognized by MedTech Breakthrough and consider it a testament to the hard work and passion of the Ventec Team to improve the lives of patients and caregivers.”

Products 2017 | Ventilation

$
0
0

Hans Rudolph’s new Eagle 1 and Eagle 2 Masks are disposable single-patient use oronasal masks intended to administer oxygen or other breathing gases into the upper airway for short-term or emergency applications of noninvasive respiratory support or ventilation (NIV) in hospitals, transport vehicles, institutions, or other clinical settings.

The Eagle 2 Series mask has a supplemental, membrane-sealed port for use during insertion of a bronchoscope or other endoscopic device into the patient’s airway while still administering oxygen and other breathing gases. This mask also has a hose barb and female luer integrated in the mask dome. 800-456-6695; www.rudolphkc.com


Drager EvitaDräger’s Evita Infinity V500 critical care ventilator is suitable for all patient ranges: neonatal, pediatric, and adult. It offers new concepts in ventilation, such as APRV with auto-release, configurable SmartCare/PS, and variable PS. It’s standardized nomenclature and customizable interface improves workflow and enhances ICU safety. The V500’s ability to provide invasive, noninvasive, and O2 therapy offers a comprehensive array of therapy to adapt to the patient’s changing requirements. 800-437-2437; www.draeger.com


ventilation_Ventec_VOCSN-1-315Now available from Ventec Life Systems, VOCSN integrates five separate devices, including a critical care ventilator, 6 LPM equivalent oxygen concentrator, Touch Button Cough assist, hospital grade Suction, and high performance Nebulizer, into one unified respiratory system. The VOCSN critical care ventilator provides invasive, noninvasive, and mouthpiece ventilation. Designed to work in hospital, institutional, transport, and home environments, VOCSN delivers a comprehensive set of ventilation modes and settings to meet patient’s needs. The advanced unified respiratory system combines responsive leak and circuit compensation as well as precision flow trigger controls to enable comfortable breathing and accurate therapy. 844-MY-VOCSN (844-698-6276); www.venteclife.com


Drager BabylogThe Babylog VN500 from Dräger is a ventilation system designed to meet the unique challenges of the neonatal patient. The Babylog VN500 offers a wide array of neonatal features to minimize lung injury, improve safety, and improve the environment of care for infants to thrive. Accurate tidal volume delivery as low as 2cm3, measurement and compensation for ET tube leakage, and volume guarantee options ensure proper ventilation and monitoring of the smallest of patients. In addition to conventional ventilation therapies, the Babylog VN500 can provide non-invasive ventilation and O2 therapy which can greatly
improve the workflow for clinicians. 800-437-2437; www.draeger.com


Ventilation_Maquet_ServoU-275The Servo-U, from Maquet, is designed to making protective ventilation more accessible, understandable, and easy to implement. The device can be used on neonates through adults and has a completely touch-based interface that helps clinicians manage ventilation. The Servo-U is equipped with NAVA (Neurally Adjusted Ventilatory Assist) technology and Edi (electrical diaphragmatic) monitoring for enhanced patient-ventilator interaction and greater insight into patient respiratory condition. The platform is designed to grow with the customer and can be upgraded easily and cost-effectively. 888-627-8383; www.maquetusa.com 

2017 Product Issue Now Available

$
0
0

RT Magazine’s annual Product Issue is now available in via Digital Edition on your web browser or mobile device.

Included in the issue is information on the industry’s newest medical devices and technologies, including the latest products in ventilation, secretion clearance, resuscitation, CPAP, and more. Learn more about some of the industry’s newest products now.

View RT’s 2017 Product Issue here.

 

Halyard Health Releases Oral Care Kit for Smaller Patients

$
0
0

Halyard Health has launched the Halyard Mini 24-Hour Oral Care Kit for smaller patients. The kit is the latest addition to Halyard’s portfolio of flexible, easy-to-use kits and components designed to promote oral care compliance. The product is available today for order.

The comprehensive kit provides all the benefits of the Halyard Adult Oral Care in a kit that is “right-sized” for smaller patients, the company said in a press release.

The kit incorporates all of the existing features of the standard Halyard 24-Hour Oral Care Kit including individual color-coded packs with order-of-use guidelines, a self-cleaning Yankauer, a small size toothbrush, and a convenient wall hanger.

Additional features include:

  • 8-French suction catheter: A catheter designed for smaller patients to cleanse secretions and debris from the shaft after suctioning, leaving it drier and cleaner between uses.
  • Smaller swabs: Smaller swabs with rounded tips designed to provide a better fit for patients with smaller mouths.
  • Alcohol-free mouthwash: An alternative to traditional mouthwash for small patients.

 The Halyard Mini 24-Hour Oral Care Kit is intended for critical care nurses and Intensive Care managers, to better aid smaller patients, the company noted.

“According to the Centers for Disease Control and Prevention, when patients are put on ventilators, consistent oral care routines are necessary to prevent ventilator-associated pneumonia (VAP) and other infections. Hospitals and healthcare facilities often perform oral care on smaller patients, which requires using more petite components. The Halyard Mini 24-Hour Oral Care Kit addresses the need to protect even the smallest patients from VAP and other infections,” the company said in a press release. 

NIV and COPD Readmissions: Clinical Implications of the HOT-HMV Study | A Philips Respironics Symposium

$
0
0

Dr Nicholas Hart, the joint editor-in-chief of Thorax and professor of Respiratory & Critical Care Medicine at St Thomas Hospital (London), discusses the results of the HOT-HMV study on the effects of noninvasive ventilation for preventing COPD readmissions.

This mini-symposium was sponsored by Philips Respironics and filmed at the American Thoracic Society annual meeting on May 23, 2017 in San Francisco. More information is available at www.respironics.com.

Watch the video here.

 

 

Cloud-connected Trilogy Ventilator Launched by Philips

$
0
0

Royal Philips has commercially released its wirelessly connected Trilogy family of portable ventilators in North America.

Now connecting to Philips cloud-based Care Orchestrator patient management application, Bluetooth-enabled Trilogy devices turn medical-grade data into actionable information, delivering it directly to mobile devices or desktops of care providers multiple times per day. This solution enables care teams to monitor patients remotely and proactively, allowing for fast and informed clinical decisions including early intervention, which can help avoid unnecessary readmissions and lower cost of care.

“In order to have a meaningful impact on patient outcomes, we need to work closely with care providers and develop technologies that can help them break the cycle of reactive care,” said Eli Diacopoulos, Respiratory Care Business Leader, Philips. “By connecting Trilogy to Care Orchestrator, we are further blurring the lines between hospital and home, and enabling interventions that could help to reduce hospitalizations and improve quality of care.”

As part of Philips’ ongoing co-development efforts, connected Trilogy debuted with a limited release in late 2016 with select medical equipment providers. These partners have been managing ventilation patients and providing feedback to help further enhance the connected Trilogy solution.

“Connected Trilogy will contribute to operational and cost efficiencies for our business,” said Amy Day, Director of Clinical Strategy with MedSouth, Inc. and limited release participant. “We will be able to manage patients proactively instead of reactively, identifying triggers and monitoring compliance as opposed to waiting for a follow-up appointment or receiving a call that a patient has been re-hospitalized.”

Philips Trilogy is a proven portable ventilation solution that has helped hundreds of thousands of pediatric and adult patients by effectively transitioning them from the hospital to the home. The announcement of its connectivity follows a recent study using Trilogy with AVAPS-AE, which found that a multi-faceted approach to COPD treatment using non-invasive ventilation could significantly decrease hospital and payer costs as well as hospitalization rates for patients with severe COPD. When paired with Philips Care Orchestrator, Trilogy connects patients, homecare providers, physicians and payers within a single cloud-based platform, helping health systems to simplify day-to-day operations while leveraging informatics to deliver personalized connected care.

The medical-grade connectivity of Philips Trilogy ventilators is powered by Philips HealthSuite and Qualcomm Life’s 2net Platform. Since 2016, Philips and Qualcomm have had a strategic technology collaboration to advance connected health across the health continuum.


Pinnacle Sciences Developing 4-in-1 Ventilating Mask

$
0
0

Pinnacle Sciences is developing a portable, battery-operated “Ventilating Mask” that will incorporate CPAP, bi-level, full ventilation, cough assistance,and high-frequency modes. Later models will also allow for invasive ventilation options. The device line is expected to cost approximately $330.00, with a bundled mask, according to the company.

ventilating-mask-PinnacleSci-275Unlike conventional devices that require a tube to connect from a power unit, this device fits directly on the mask, completely eliminating dead space. This allows for lower pressures to be used, which the company claims will mean significantly increased comfort for the patient. The device can also be used with a tube, be clothes mounted, or put in a pocket.

“We are very proud of this new patented technology, which is set to shake the CPAP/Bi-Level/Cough Assistance and Ventilator markets to the core,” said Wolf Hayek, president and CEO of Pinnacle Sciences. “The proposed price point of this device, we believe, will shake out the weaker players in the respiratory and sleep markets, and send a shock wave through the industry as a whole. The phrase game changer is often thrown around. This technology will likely end the game for some, and allow others to play it in a completely different way altogether.”

More information is available at the company’s website.

Frost & Sullivan Award Goes to Philips Ventilators

$
0
0

Frost & Sullivan has recognized Philips with the 2017 North American Home Ventilation Product Leadership Award for its Trilogy series of home care ventilators, according to a company news release. Trilogy ventilators are cost-effective, invasive and non-invasive, with multi-mode capabilities providing easy-to-view and -share data for near-real-time patient care.

The Trilogy 100 and Trilogy 200 ventilators are compact, portable, and have multiple circuit choices to help clinicians caring for patients with different chronic respiratory conditions and ventilation requirements.

According to Philips, the prevalence of respiratory disease creates pressure on care providers and vendors to create population health management solutions to replace existing episodic care protocols. With reimbursements shifting away from traditional fee-for-service models to value-based care, hospitals are increasingly required to demonstrate improvements in care provision to qualify for reimbursements, including faster discharge rates, lower inpatient bed days, lower readmission rates, and better follow-up care and post-treatment management.

To address these issues, ventilator manufacturers need to look at a combination of products and solutions to appeal to patients with chronic diseases, both at home and in sub-acute facilities. To help prevent hospitalization, the best ventilation products will be able to share ventilation data seamlessly with care providers, Philips says.

“It’s worth noting that, in the United States, clinicians are using Trilogy 100 and Trilogy 200 ventilator units to treat hundreds of thousands of patients with different respiratory conditions, said Senior Research Analyst, Tanvir Jaikishen. “Philips’ extensive experience in IT really strengthens and distinguishes it from competitors in the home ventilation space.”

“Philips Trilogy ventilation products provide hospitals with improvements in care provision, including faster discharge rates, lower inpatient bed days, lower readmission rates, and better follow-up care and post-treatment management,” added Jaikishen. “This really helps hospitals to better adapt to the emergence of quality-based care payment models in the healthcare industry.”

Frost & Sullivan Innovation Award Goes to VOCSN

$
0
0

Frost & Sullivan has recognized Ventec Life Systems with the 2017 North American Frost & Sullivan Award for New Product Innovation for its portable unified respiratory system, VOCSN. The device, combines a critical care ventilator, 6 LPM equivalent oxygen concentrator, Touch Button Cough assist, hospital grade suction, and high performance nebulizer in a single device, received FDA clearance in April 2017.

According to Ventec Life Systems, VOCSN improves quality of care and creates a substantial cost savings for patients, payers, and caregivers. The unified device not only lowers the cost of acquisition, storage, maintenance, and training, but also consumes less power than systems that require multiple devices.

“VOCSN’s battery life of up to nine hours and weight of 18 lbs makes it both lightweight and portable, facilitating its use in multiple care settings such as hospitals, sub-acute care facilities, long-term care facilities, transport, and patients’ homes,” said Frost & Sullivan Senior Research Analyst Tanvir Jaikishen. “It also demonstrates high customizability in treating a range of conditions such as chronic respiratory diseases, autoimmune diseases, and various forms of muscular dystrophy and spinal cord injuries. VOCSN demonstrates a long overdue move to develop integrated medical devices that are easier to use in the hospital and home matching similar advancements more common with consumer electronics rather than complicated and sometimes confusing medical devices.”

Significantly, patients are not required to purchase all five functionalities of VOCSN and only need to invest in the features they require, according to the company. Ventec plans to continue their growth in Europe and Asia in a phased manner between 2017 and 2018.

Dräger Continues Tradition of Gifting Ventilators to RT Schools

$
0
0

To help foster a greater learning experience for respiratory therapy (RT) students, Dräger donated 12 V-Series ventilators to respiratory therapy schools in the US during AARC 2017, October 4-7, 2017, in Indianapolis.

“The company is honored to provide the latest mechanical ventilation technology to RT professionals, who are critical to the future of healthcare,” the company said in a press announcement.

RT students at 12 institutions can now train on modern Dräger ventilators, which are well-known around the world for quality and reliability, the company noted.

The RT programs were: Arkansas State University, Blessing-Rieman College of Nursing & Health Sciences, Jefferson College of Health Sciences, Laurel Business Institute, Louisiana State University (LSU), Manchester Community College, Middle Georgia State University, Midwestern State University, Palm Beach State College, Salt Lake Community College and St. Catherine’s University.

A twelfth ventilator was donated to Lone Star College-Kingman after Hurricane Harvey destroyed the cardiopulmonary teaching lab in the Houston area.

Hospitals face enormous challenges attracting qualified RTs to meet the increasing demands of an aging population and an evolving healthcare marketplace. Demands on institutions of higher learning that offer respiratory care education are on the frontlines of training the next generation of dedicated respiratory professionals. Key to preparing new RTs is the ability to provide advanced training on modern-day mechanical ventilators within a simulated lab setting.

“As a corporate partner of AARC, and a company dedicated to life-saving technologies, Dräger takes pride in its corporate and social responsibilities,” said Ed Coombs, MA, RRT-NPS, ACCS, FAARC, director of marketing for Intensive Care, Draeger, Inc. “By providing leading innovations in respiratory care to the next generation of RT professionals, we hope to play a part in improving patient outcomes while maintaining cost effectiveness.”

More information is available on the Dräger website.

NeoTree Tube Support for Neonatal and Pediatric Ventilator Circuits

$
0
0

Respiralogics recently released its NeoTree Tube Support device, which provides a stable holder for tubing used with neonatal and pediatric ventilator circuits.

The NeoTree Tube Support is reversible in position to accommodate ventilator circuits and tubings. It is constructed of lightweight aluminum with a baked-on power coat finish. The tube holder is reusable, durable and easily cleaned.

NeoTree Tube Support assists in the reduction of tension on the endotracheal tube or face mask to prevent kinking of the circuit, inadvertent extubations and/or movement of the endotracheal tube or mask in NICU, PICU, Surgery and Clinic settings.

More information is available on the company’s website.

Fluke Biomedical Launches Two Gas Flow Analyzers

$
0
0

Fluke Biomedical has introduced the VT650 and VT900 Gas Flow Analyzers, which include one-channel, full-range air flow functionality that streamlines testing.

The VT650 and VT900 offer accuracy and reliability for gas flow and respiratory medical equipment testing, including all types of ventilators, flow meters, pressure gauges, and anesthesia and other machines.

The VT650 features a full-range ±300 liter-per-minute (lpm) airflow channel with built-in oxygen, temperature, and humidity measurements. Designed and tested to world-renowned Molbloc-L calibration specifications, it ensures traceability to global regulatory standards and is great for basic ventilator and gas-flow testing.

The VT900 has all the ease-of-use and features of the VT650, plus an external TTL trigger input and special ultra-low flow and ultra-low-pressure ports for high accuracy in critical low volume and pressure testing such as for anesthesia machines and flow meters.

With the VT650 and VT900, biomedical technicians can:

  • Save time and avoid errors with customizable test profiles and data recording using on-board memory.
  • Avoid confusion and ensure accuracy with one-channel, full-range air flow functionality.
  • Reduce testing time with built-in line sensors that automatically test humidity, temperature, and oxygen while compensating for atmospheric pressure and environmental conditions.
  • Easily transport and store the lightweight (3.6pound/1.6 kilogram), all-in-one devices – with no extra modules for different tests.
  • Quickly access menu options, interpret results, and see measurements at a distance up to six feet (1.8 meters) with the large, easy-to-read seven-inch color touchscreen. Test results can be displayed as color graphs in real time and its global user interface provides simple operation.
  • Operate all day with eight hours of rechargeable battery life.

The analyzers’ large onboard memory allows storage of customized test profiles and testing of multiple medical devices back-to-back without having to transfer data between tests — data is simply recorded and stored, saving time. When testing is completed, saved data can be transferred via the USB port to a PC and test results uploaded to CMMS systems for easy documenting and reporting.

More information is available on the company’s website.

Ventilation and Airway Management during NICU/PICU Transport

$
0
0

Successful transport relies on a combination of the right equipment, proven safety protocols, and the expertise of clinicians.

neonatal-icu-nicu-hospital-500

Transferring critically-ill neonatal and pediatric patients for diagnostic or therapeutic purposes can prove to be a challenge for healthcare facilities in terms of proper care and safety of the patients. The success of NICU/PICU transports relies heavily on proven safety protocols, proper ventilation and airway management equipment and technology, and, most importantly, the expertise of clinicians like respiratory therapists (RT). Without these important factors, the patients could be at risk of serious and sometimes fatal adverse events.

The Role of the RT

Respiratory therapists play a critical role during transport of neonatal and pediatric patients. They offer expertise in treatments for respiratory medicine, cardiopulmonary pathophysiology, and the employment of proper technology and equipment to provide optimum care for young, critically ill patients who are in need of an inter-facility transport (IFT).

“The vast majority of specialized neonatal and pediatric transport teams are staffed by an RN and an RRT,” said Steve Sittig, RRT-NPS, CNPT, FAARC. “The use of RTs in medical transport began in the 1970s when specialized neonatal transport was developed. In the 1980s, more institutions began to develop specialized pediatric transport teams of which respiratory therapists were considered an integral team member.”

Now, he said, almost all progressive neonatal and pediatric specialty transport teams utilize the transport RT for many advanced procedures such as intubation, peripheral IVs, arterial line placement, point of care blood analysis, and chest tubes for pneumothorax. “These advanced skills can vary from institution to institution,” he added.

Sittig also explained that many teams are now requiring transport RTs to hold the RRT credential, as well as the neonatal pediatric specialty (NPS) credential or the certification of neonatal pediatric transport (CNPT).

“For transport teams who are certified by the Commission on Accreditation of Medical Transport Services (CAMTS), these advanced credentials will be required by 2019 when the 11th Edition of the CAMTS Standards are published,” he said. “These advanced exams show that the transport RT understands the unique environment of transport along with specific pathophysiologies typically present in this population requiring medical transport.”

Best Practices and Proper Protocols

In a 2012 study,1 researchers investigated the risk factors associated to clinical deterioration in neonatal patients during IFT. The research team looked at the Transport Risk Index of Physiology Stability (TRIPS) risk score—which has shown efficacy2 in predicting early mortality at admission—in 160 newborn infants pre- and post-transport. A diagnosis of clinical deterioration was made if the score was higher post-transport. The results showed a staggering 91 (57%) neonatal patients suffered clinical deterioration during IFT; 49 of those patients required immediate cardiorespiratory support (ICRS) and 28 died post-transport.

This study concluded that it is crucial for transport teams to optimize care strategies in order to deter the deterioration of young, vulnerable patients during IFTs, which will in turn reduce the number of patients who require ICRS as well as lower mortality rates.

It goes without saying there are significant risks to transporting critically-ill neonatal and pediatric patients. From failed intubations to overcooling to safety for both patients and clinicians, the transport team must be prepared to address these risks using proven best practices and up-to-date protocols.

Bradley Kuch MHA, RRT-NPS, FAARC, director of respiratory care services and transport team at the Children’s Hospital of Pittsburgh of UPMC, describes some of the things he and his team have in place that have been shown to improve outcomes.

“One practice we use is active cooling, which has been shown to be very successful and produce good outcomes. Most teams right now are doing passive cooling, but we believe actively controlling temperatures is definitely the best way to go,” he said.

Research backs up Kuch’s assessment of active versus passive cooling. In one study, published in the journal Pediatrics,3 researchers set out to compare outcomes between passive and active cooling. Of the 134 patients transported, 64 were passively cooled—and only 39% of the patients were within the target temperature range when arriving to the receiving facility. In contrast, an impressive 100% of patients that underwent active cooling were within the target temperature range. Active cooling was shown to improve temperature stability, decrease the incidence of overcooling, and reduce stabilization and transfer time, according to the authors of the study.

A good response time by the transport team is also crucial when it comes to neonatal patients, especially during the first hour of a patient’s life, also known as the golden hour. “In neonatal and pediatric critical care transports,” said Kuch, “the golden hour for us is getting that highly specialized team to the hospital to prepare the patient, and initiating proper communication with the outside facility.” An integral part of the team’s communication system are their specialized command positions: one for the NICU who is a neonatologist, and one for the PICU who is a pediatric intensivist. “They act as the point person for hospital transports and play a big role in getting the teams ready as quickly as possible, and facilitating communication between facilities,” he says.

“One of the biggest things I believe helps our patients and our team in airway management is our use of the video guided intubations,” said Olivia Kaullen, RRT-NPS. She says she not only uses this technology to help herself intubate better, but also for education and for allowing other team members to help guide the intubation if necessary. “It is our protocol to use this device first every time we intubate. Our first-attempt intubation rate has actually improved which may be due to this policy.”

Kuch added that it is important to always keep in mind the safety of the patient and crew. “The assessments need to be looking at having the right equipment to protect them; protecting the patient from loud noises, making sure vehicles are operated safely and effectively, making sure the patient is secured at all times, and so on.”

A major factor when it comes to safety is during inclement weather. “If for any reason they team feels that the weather of patient condition is not conducive to safe transport, most transport team use the phrase ‘All to go, one to say no,’” said Sittig. “So, if any one team member is not comfortable with the weather conditions, the transport may be delayed until weather improves. If you look at the history of medical transport accidents, most occur when programs push the weather in order to complete a transport.”

Improving Outcomes with Innovative Equipment

“The advent of new technology has vastly improved quality of care in transport,” said Sittig. “New transport ventilators can rival hospital ICU vents for adaptive modes of ventilation, and transport RTs can now bring these new modes of ventilation to the patient wherever they are located.”

One of these modes of ventilation is the Hamilton-T1, created by Hamilton Medical and designed specifically for fragile neonates, which performs on the same level as an NICU bedside ventilator. This product features an nCPAP-PC (pressure control) mode in which the RT defines the desired CPAP target value of a patient and the ventilator adapts the required flow to the patient’s condition. In turn, the patient receives only as much flow as is necessary to reach the target value. According to the company’s press release, this reduces work of breathing and the need for user interventions, and also ensures optimal leak compensation.

NeoTech Products also has a couple products on the market designed to make IFTs easier. The NeoBar ET Tube Holder is designed to reduce extubations, help prevent palate trauma and allows for better oral care. It also eliminates the need to tape near the patient’s nose or mouth. Another product they offer is the NeoGrip Tubing and Cable Holder, which helps to keep tubes, cables and circuits together and allows for better patient mobility.

Kaullen warns that while there is a lot of technology that transport teams can use to better care for patients, none of it can reach its full potential if the team is not trained to use it appropriately. “It is very important that the personnel using the respiratory equipment not only understand how to use it appropriately, but also how it works and how to troubleshoot it,” she said. “When you’re out in the field, you can’t have another RT come help you—you must be knowledgeable for the sake of your patient.”

The Necessity of Experience and Communication

In a retrospective study4 aimed at evaluating and identifying potential complications during IFT of critically-ill pediatric patients, researchers found that the most significant obstacle faced during the process was a lack of knowledge or experience of the transport team to perform safe, effective transfers. The abstract, published in the Journal of the Medical Association of Thailand, concludes that in order to improve the outcomes and avoid the potential adverse events during IFT, it is imperative that the transport team be organized and prepared with proper safety protocols.

Kuch believes that a well-experienced and prepared team of clinicians is the key to successful transfers. “Both our nurses and therapists, as well as other physicians, are required to have at least three years of neonatal and/or pediatric experience, because that is the best way to ensure that we reach the best outcomes for the patient,” he said.

In a single-center, prospective, cohort study5 published in the journal Pediatrics, researchers hypothesized whether a specialized pediatric team, compared to a non-specialized team, would improve rate of survival as well as lower unplanned, adverse events during transport. The study concluded that the non-specialized team was associated with a higher frequency of unplanned, adverse events, as well as a higher rate of mortality among pediatric patients. This shows that having a well-rounded, specialized critical care team is associated with better outcomes for patients during IFT.

“I think communication and collaboration is another key to a successful and reliable transport team,” said Jennifer Mahone, MHA, RRT-NPS, neonatal/pediatric clinical specialist at Reading Hospital. “Truly making sure that everything is in place to keep the patients safe by working and communicating with the whole transport team is important for any hospital that provides these services.”

While good communication within the specialized team is a vital component to successful transfers, Kuch says it is also important to note the significance of proper communication and collaboration with outside facilities who are referring or receiving the patient. “We are in what I would call a ‘resource-limited environment’ and it is really important that everyone on our end works with outside resources to help things get done the right way,” said Kuch. “I’d be remiss to not point out that good partnerships with those referring hospitals is key. It’s important that both the referring and receiving hospital provide good recommendations and different input for the patients. You need to have a good relationship with the outside hospital because, at the end of the day, both systems have the same goal in mind—providing optimal care for the patient.” RT


Dillon Stickle is associate editor of RT. For more information, contact editor@nullRTmagazine.com.


References

  1. https://www.ncbi.nlm.nih.gov/pubmed/22859323
  2. https://www.ncbi.nlm.nih.gov/pubmed/22495897
  3. http://pediatrics.aappublications.org/content/132/5/841.full
  4. https://www.ncbi.nlm.nih.gov/pubmed/16858849
  5. https://www.ncbi.nlm.nih.gov/pubmed/19564281

Webinar: ARDS & Ventilation in the ICU

$
0
0

On March 28, 2018, RT Magazine will host a free webinar on ARDS & Ventilation in the ICU.

At an estimated hospital cost of over $125,000 per patient, acute respiratory distress syndrome (ARDS) is a frequent cause of morbidity and mortality in intensive care units. In this live webinar hosted by RT Magazine, industry experts will discuss steps to monitor and prevent the condition in the ICU and successful interventions using ventilation.

This webinar is generously sponsored by Dräger.

DATE: Wed March 28, 2018
TIME: 1:00pm ET (60-min duration)

REGISTER HERE.

PANELISTS

headshot_niemanG90Gary Nieman, BS, MS
Associate Professor and Director, Cardiopulmonary and Critical Care Lab
SUNY Upstate Medical University (Syracuse, NY)

Gary Nieman is an Associate Professor and Senior Research Scientist in the Department of Surgery at the Upstate Medical University (Syracuse, NY) and is also the director of the Cardiopulmonary and Critical Care Laboratory. Nieman studies the pathogenesis and treatment of ARDS and ventilator induced lung injury (VILI).

 

headshot_pasewald90Ron Pasewald BS, RRT-ACCS
Lead Respiratory Care Practitioner
Froedtert Hospital (Wauwatosa, Wisc)

Ron Pasewald is a Lead Respiratory Care Practitioner at Froedtert Hospital in Milwaukee Wisc. Pasewald is a graduate of Respiratory Care from Western Wisconsin Technical College (Lacrosse, Wisc) and a Bachelor’s of Science degree from University of Wisconsin Oshkosh in Microbiology/Chemistry. He currently serves as President of the Wisconsin Society for Respiratory Care and has been lecturing on the proper utilization of airway pressure release ventilation for nearly a decade, participating in numerous clinical studies, experiments, and abstracts on the topic.

 

headshot_RowleyD90Daniel D. Rowley, MSc, RRT-ACCS, RRT-NPS, RPFT, FAARC
Clinical Coordinator, Pulmonary Diagnostics & Respiratory Therapy Services
University of Virginia Medical Center (Charlottesville, Va)

Daniel Rowley is Clinical Coordinator for Pulmonary Diagnostics & Respiratory Therapy Services at the University of Virginia Medical Center in Charlottesville, Virginia. He earned a master’s degree in respiratory care from Northeastern University and holds NBRC credentials as a registered respiratory therapist with specialty credentials in adult critical care. His clinical interests include all aspects of adult critical care, and research interests include lung protective mechanical ventilation, patient-ventilator synchrony, and electrical impedance tomography monitoring of regional distribution of ventilation.

FDA Approves New ExSpiron Minute Ventilation Device

$
0
0

The FDA has cleared the newest version of Respiratory Motion Inc’s ExSpiron Minute Ventilation (MV) monitoring system. The device will launch at the Society for Pediatric Anesthesia-American Academy of Pediatrics in PhoenixMarch 23-25.

Respiratory failure can occur anywhere in the hospital and early detection can often make the difference between life and death. MV monitoring is the most direct measure of respiratory status, providing the earliest warning of changes in respiratory status. Sufficient time to act is crucial in preventing bad outcomes. Respiratory Motion’s ExSpiron is the first and only continuous Minute Ventilation Monitor that has been cleared for broad use in hospital and ancillary medical settings.

The ExSpiron has previously been used across a variety of medical environments, providing real time, point-of-care data to improve the care and hospital experience of adult patients receiving opioids and/or sedatives and those at increased respiratory risk, such as patients with COPD (emphysema), congestive heart failure, sleep apnea, abnormal response to pain medications, etc. A clinical study reported by Dr. Viviane Nasr and colleagues from Children’s Hospital of Boston in December 2017 in the prominent medical journal Anesthesia and Analgesia, laid the groundwork for FDA clearance of the ExSpiron for use in children one year of age and older.

Respiratory Motion CEO, Dr. Jenny Freeman, previously a practicing pediatric cardiovascular surgeon, noted that “it is particularly rewarding to be able to bring the ExSpiron’s life saving advantages to the vulnerable pediatric population. It is very challenging to manage pain in our small patients and we have been striving to create a device to help optimize both the safety and the comfort of hospitalized children. We are now working to extend the technology to benefit newborns and premature infants. Respiratory Motion is committed to building technology that can be used to improve the care of everyone, everywhere.”

Whereas other technologies focus on reducing “Failure to Rescue” in the hospital, i.e. identifying the patient in time that he can be rescued from death, the ExSpiron provides an earlier identification of changes in respiratory status and thereby the opportunity to “Avoid the Need for Rescue.”  This approach provides both an outcome advantage for the patient and a cost advantage for the hospital. The sensitivity of the ExSpiron to report early changes and unlike other respiratory monitoring technologies, the ExSpiron’s extremely low false alarm rate (even with the aggressive motion seen in children), the ExSpiron is positioned to help caregivers in their quest to achieve both patient safety and patient (and family) satisfaction.

Respiralogics Introduces 30500 Series Baby Head Band and Circuit Bumpers

$
0
0

For clinicians needing a more comfortable and versatile way to secure nasal prongs on their most demanding patients, Respiralogics Inc has released the 30500 Series Baby Head Band and Circuit Bumpers. The Baby Head Band and Circuit Bumpers are intended to secure the nasal interface during oxygen therapy, nCPAP or NIV therapy.

The Baby Head Band is made of breathable, non-latex foam that absorbs and wicks away moisture leaving the scalp and skin dry. The soft material of the head band allows it to conform to even the tiniest of heads while maintaining the circuit position. The soft outer covering of the Baby Head Band allows for easy head movement while holding the nasal prongs and circuit stable.

The new reversible Circuit Bumpers secure and stabilize the position of the inspiratory and expiratory limbs to the soft outer side of Head Band while providing optimal positioning for infants of all shapes and sizes. The Head Band and Circuit Bumpers work in conjunction with neonatal/pediatric ventilator circuits and oxygen therapy tubing.

Benefits include:

  • Fashioned to provide a comfortable fit for all infants
  • Sized by head circumference for easy and quick application
  • Reversible Velcro Bumpers allow for secure attachment and minimize pressure points
  • Allows caregivers to freely move infant without interrupting therapy
  • Opened at the crown for fontanel checks and to accommodate scalp vein IV’s
  • Available in four (4) sizes for very low birth weight up to 10 kg infants
  • Single Patient Use, non-latex material

Designed for use in NICU, PICU, surgery and clinics for stable positioning of nasal interface. Respiralogics specializes in providing innovative respiratory care products to meet the challenging needs of respiratory patients. To benefit clinicians, we have joined with leading specialty respiratory distributors to provide expert local assistance and the training required for successful implementation of our products. The Respiralogics complete line of products are available from Respiralogics and our specialty respiratory care distributors.

Vyaire Medical to Acquire Ventilator Division from imtmedical

$
0
0

Vyaire Medical Inc has signed an agreement to acquire the ventilator business and the imtmedical brand name, according to a press release from imtmedical. A second business unit that includes test lungs will remain with the Switzerland-based IMT Analytics.

“With this step, we want to help bellavista ventilators achieve the success they deserve. To reach this target, it requires a company like Vyaire, which already has strong distribution and financial structures worldwide,” said Jakob Däscher, one of the founders of imtmedical.

The company will continue to operate from their current location in Buchs, Switzerland, which also applies to imtmedical ag under Vyaire in the coming years, according to the press release.

“In order to maintain the stable operation of imtmedical, there will be no adjustments to the site or personnel in the foreseeable future,” explained Harri Friberg, former CEO of imtmedical. At the beginning of May, discussions will be held with employees who will be integrated into Vyaire or who will switch to IMT Analytics.

The sale of the ventilator business unit brings benefits to users of all products previously offered by imtmedical. It is now possible for IMT Analytics and its development partner IMT AG to concentrate more on the development and optimization of measuring instruments. In addition, IMT AG will be responsible for the development and lifetime maintenance of the ventilation products from Vyaire for the next few years.

“For us, this contract is a windfall, which also reflects the high quality of our development services,” said Harri Friberg, managing director of IMT. In both business divisions, several devices are already in an advanced stage of development.

Products 2018 | Ventilation

$
0
0

The Servo-U, from Getinge Group / Maquet, is designed to making protective ventilation more accessible, understandable, and easy to implement. The device can be used on neonates through adults and has a completely touch-based interface that helps clinicians manage ventilation. The Servo-U is equipped with NAVA (Neurally Adjusted Ventilatory Assist) technology and Edi (electrical diaphragmatic) monitoring for enhanced patient-ventilator interaction and greater insight into patient respiratory condition. The platform is designed to grow with the customer and can be upgraded easily and cost-effectively. 888-627-8383; www.maquetusa.com


Ventilation_Ventec_VOCSN
Now available from Ventec Life Systems, VOCSN integrates five separate devices, including a critical care ventilator, 6 LPM equivalent oxygen concentrator, Touch Button Cough assist, hospital grade Suction, and high performance Nebulizer, into one unified respiratory system. The VOCSN critical care ventilator provides invasive, noninvasive, and mouthpiece ventilation. Designed to work in hospital, institutional, transport, and home environments, VOCSN delivers a comprehensive set of ventilation modes and settings to meet patient’s needs. The advanced unified respiratory system combines responsive leak and circuit compensation as well as precision flow trigger controls to enable comfortable breathing and accurate therapy. 844-698-6276; www.venteclife.com


Ventilation_International Biomedical_TXP-2D
International Biomedical
offers the TXP-2D, a lightweight, compact, and easy-to-use high frequency ventilation solution for your ground and air transport needs. The TXP-2D is nitric oxide (NO) compatible with the AeroNOx NO Delivery System and features a digital LCD. It is pneumatic powered and provides 350-500 BPM. 512-873-0033; int-bio.com.com


 

Ventilation_Philips_V60The Philips Respironics V60 ventilator offers ICU-grade NIV performance with enhanced monitoring and alarms. The V60 uses auto-adaptive technology to help provide patient synchrony and therapy acceptance. With a six-hour battery, it is flexible enough for intra-hospital transport and offers treatment for a wide range of clinical severities for patients from pediatric to adult. 800-345-6443; www.usa.philips.com/healthcare


Ventilation_Hamilton_G5
Hamilton Medical
offers the Hamilton-G5, their most modular mechanical ventilator. A large set of standard features and options allows you to tailor the Hamilton-G5 to your needs. The integrated cuff pressure controller, IntelliCuff, continuously monitors and automatically adjusts cuffed tracheal and tracheostomy tubes, providing real-time optimization of cuff pressure. 800-426-6331; www.hamilton-medical.com

 


Ventilation_Dräger_V500
The Evita Infinity V500, from Dräger, is a critical care ventilator that is suitable for all patient ranges. It offers new concepts in ventilation, such as APRV with auto-release, configurable SmartCare/PS and variable PS. It’s standardized nomenclature and customizable interface improves workflow and enhances ICU safety. 800-437-2437; www.draeger.com


 

Ventilation_Hayek_Biphasic CuirassHayek Medical offers the Biphasic Cuirass Ventilation (BCV), which provides complete, noninvasive ventilation by replicating our natural breathing cycle through a cuirass shell. BCV is an alternative to traditional forms of ventilation. BCV also has secretion clearance (HFCWO) and a cough option. BCV can be used both in the hospital setting or at home. 855-243-8228; www.hayekmedical.com

 


Ventilation_GEhealth_CarescapeR860
The Carescape R860 ventilator, from GE Healthcare, is designed with a human-centered user interface that replaces menus with workspace views to flatten the learning curve & unlock ventilator capabilities, making them more accessible and easier to use. Combining metabolics and lung protective capabilities, the Carescape R860 offers clinicians the ability to deliver personalized ventilation therapy. 866-281-7545; www.gehealthcare.com

Viewing all 104 articles
Browse latest View live